A Tailored Interactive Website for Promoting Condom Use Among Young Adults (Youthnet)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00183638|
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : November 27, 2013
|Condition or disease||Intervention/treatment||Phase|
|HIV Infections Sexually Transmitted Diseases||Behavioral: Internet-based tailored prevention messages Behavioral: Non-tailored messages||Phase 2|
Adolescents and young adults are at the greatest risk for acquiring a sexually transmitted disease (STD). Approximately 3 million people between the ages of 18 and 24 become infected with an STD each year. Education about the risks and consequences of unprotected sex is a powerful tool that can be used to prevent or reduce the risk of infection. The program in this study will deliver messages to educate participants about condom use and the risk of STD infection. The study will evaluate the effectiveness of a tailored interactive online risk reduction program versus a standard online risk reduction program in reducing the risk of STD infection in young adults.
Participants in this open-label study will be recruited from one of two clinics in the Denver, Colorado area: Denver Metropolitan Health Clinic or Planned Parenthood of the Rocky Mountains. Participants will be randomly assigned to receive internet-based messages from either the Youthnet program or the control program while filling out a risk assessment survey. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage. The control program will deliver 5 general, non-tailored messages containing information on reproductive health not specific to condoms or STDs. Participants will be assessed at baseline and a follow-up session 3 months after enrollment. Frequency of condom use and attitudes toward condom use will be assessed using behavioral scales.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1870 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Randomized Controlled Trial to Establish Efficacy of a Website to Promote Condom Use for Adults Aged 18-25|
|Study Start Date :||June 2003|
|Actual Primary Completion Date :||December 2008|
|Actual Study Completion Date :||December 2008|
Participants will receive Internet-based tailored prevention messages
Behavioral: Internet-based tailored prevention messages
Participants will receive five 30-second flash clips promoting condom norms, positive attitudes, self-efficacy, and risk awareness. Participants in the Youthnet program will be asked their gender and ethnicity so they may be assigned to a role model of the same gender and ethnicity via a computer program. This role model will appear online 5 times during the survey to deliver interactive messages that will be tailored to HIV/STD risk reduction and will specifically address attitudes about condom usage.
Other Name: Youthnet
Active Comparator: 2
Participants will receive non-tailored messages containing information on reproductive health
Behavioral: Non-tailored messages
The control program will deliver five general, non-tailored messages containing information on reproductive health not specific to condoms or STDs.
- Condom use with non main partners [ Time Frame: Measured at Month 3 ]
- Self-efficacy for condom use and condom negotiation [ Time Frame: Measured at Month 3 ]
- Attitudes and norms towards condom use [ Time Frame: Measured at Month 3 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00183638
|United States, Colorado|
|University of Colorado Health Sciences Center|
|Aurora, Colorado, United States, 80045-0508|
|Principal Investigator:||Sheana S. Bull, PhD||University of Colorado, Denver|